Trials / Conditions / Salivary Gland Adenocarcinoma
Salivary Gland Adenocarcinoma
3 registered clinical trials studyying Salivary Gland Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer NCT00126607 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland NCT00095563 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer NCT00028496 | National Cancer Institute (NCI) | Phase 1 |